Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “PTC THERAPEUTICS, INC.”

149 pharma patents match "PTC THERAPEUTICS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 149
Index total 30,257
Page 6 / 7

Quick answer

This filtered view shows 149 pharmaceutical patents matching "PTC THERAPEUTICS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

149 results for “PTC THERAPEUTICS, INC.” · 30,257 patents in full index Clear search

  1. US 8143257

    Substituted phenols as active agents inhibiting VEGF production

    PTC THERAPEUTICS, INC. · Granted Mar 27, 2012 · Expires Mar 22, 2032

    granted
  2. US 8129540

    Methods for the synthesis of 1,2,4-oxadiazole benzoic acid compounds

    PTC THERAPEUTICS, INC. · Granted Mar 6, 2012 · Expires Mar 1, 2032

    granted
  3. US 8101641

    Hydroxylated 1,2,4-oxadiazole benzoic acid compounds and compositions thereof

    PTC THERAPEUTICS, INC. · Granted Jan 24, 2012 · Expires Jan 19, 2032

    granted
  4. US 8076352

    Administration of carboline derivatives useful in the treatment of cancer and other diseases

    PTC THERAPEUTICS, INC. · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted
  5. US 8076353

    Inhibition of VEGF translation

    PTC THERAPEUTICS, INC. · Granted Dec 13, 2011 · Expires Dec 8, 2031

    granted
  6. US 8017636

    1,2,4-Oxadiazole benzoic acid compositions and their use in bioassays

    PTC THERAPEUTICS, INC. · Granted Sep 13, 2011 · Expires Sep 8, 2031

    granted
  7. US 8013006

    Methods for treating hepatitis C

    PTC THERAPEUTICS, INC. · Granted Sep 6, 2011 · Expires Sep 1, 2031

    granted
  8. US 7973069

    Methods for treating hepatitis C

    PTC THERAPEUTICS, INC. · Granted Jul 5, 2011 · Expires Jun 30, 2031

    granted
  9. US 7939468

    Methods of identifying compounds that target tRNA splicing endonuclease and uses of said compounds as anti-proliferative agents

    PTC THERAPEUTICS, INC. · Granted May 10, 2011 · Expires May 5, 2031

    granted
  10. US 7902241

    Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted
  11. US 7902235

    Compounds for nonsense suppression, and methods for their use

    PTC THERAPEUTICS, INC. · Granted Mar 8, 2011 · Expires Mar 3, 2031

    granted
  12. US 7863456

    Crystalline forms of 3-[5-(2-fluorophenyl)-[1,2,4]oxadiazol-3-YL]-benzoic acid

    PTC THERAPEUTICS, INC. · Granted Jan 4, 2011 · Expires Dec 30, 2030

    granted
  13. US 7829503

    Methods of identifying compounds that target tRNA splicing endonuclease and uses of said compounds as anti-fungal agents

    PTC THERAPEUTICS, INC. · Granted Nov 9, 2010 · Expires Nov 4, 2030

    granted
  14. US 7781478

    Methods for treating hepatitis C

    PTC THERAPEUTICS, INC. · Granted Aug 24, 2010 · Expires Aug 19, 2030

    granted
  15. US 7772271

    Methods for treating hepatitis C

    PTC THERAPEUTICS, INC. · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted
  16. US 7772259

    1,2,4-Oxadiazole benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Aug 10, 2010 · Expires Aug 5, 2030

    granted
  17. US 7767689

    Carboline derivatives useful in the treatment of cancer

    PTC THERAPEUTICS, INC. · Granted Aug 3, 2010 · Expires Jul 29, 2030

    granted
  18. US 7683082

    1,2,4-oxadiazole benzoic acid compositions and their use in bioassays

    PTC THERAPEUTICS, INC. · Granted Mar 23, 2010 · Expires Mar 18, 2030

    granted
  19. US 7678922

    Processes for the preparation of 1,2,4-oxadiazole benzoic acids

    PTC THERAPEUTICS, INC. · Granted Mar 16, 2010 · Expires Mar 11, 2030

    granted
  20. US 7645881

    Methods for treating hepatitis C

    PTC THERAPEUTICS, INC. · Granted Jan 12, 2010 · Expires Jan 7, 2030

    granted
  21. US 7601840

    Carboline derivatives useful in the inhibition of angiogenesis

    PTC THERAPEUTICS, INC. · Granted Oct 13, 2009 · Expires Oct 8, 2029

    granted
  22. US 7449570

    Use of nucleoside compounds for nonsense suppression and the treatment of genetic diseases

    PTC THERAPEUTICS, INC. · Granted Nov 11, 2008 · Expires Nov 6, 2028

    granted
  23. US 7419991

    3-[5-(2-fluoro-phenyl)-[1,2,4]oxadiazol-3-yl]-benzoic acid, compositions, and methods for the use thereof

    PTC THERAPEUTICS, INC. · Granted Sep 2, 2008 · Expires Aug 28, 2028

    granted
  24. US 7405233

    Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease

    PTC THERAPEUTICS, INC. · Granted Jul 29, 2008 · Expires Jul 24, 2028

    granted